KV Pharmaceutical (ANDA)
M&A
STATUS
Asset Purch.
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
Abbreviated New Drug Application (ANDA) for acne gel. The ANDA refers to the clindamycin phosphate (1%) and benzoyl peroxide (5%) gel, which is used for the topical treatment of inflammatory acne vulgaris.
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Medical Supplies
Other Industries
Other Commercial Services
Acquirer
Primary Office
- 16640 Chesterfield Grove Road
- Suite 200
- Chesterfield, MO 63005
- United States
KV Pharmaceutical (ANDA) Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore KV Pharmaceutical (ANDA)‘s full profile, request access.
Request full access to PitchBookKV Pharmaceutical (ANDA) Former Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore KV Pharmaceutical (ANDA)‘s full profile, request access.
Request full access to PitchBook